These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6129856)

  • 1. The sedative-hypnotic properties of quazepam, a new hypnotic agent.
    Barnett A; Iorio LC; Ongini E
    Arzneimittelforschung; 1982; 32(11):1452-6. PubMed ID: 6129856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies with quazepam, a new benzodiazepine hypnotic.
    Ongini E; Parravicini L; Bamonte F; Guzzon V; Iorio LC; Barnett A
    Arzneimittelforschung; 1982; 32(11):1456-62. PubMed ID: 6129857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sedative-hypnotic properties of a new benzodiazepine in comparison with flurazepam. Pharmacological and clinical findings.
    Babbini M; Torrielli MV; Strumia E; Gaiardi M; Bartoletti M; De Marchi F
    Arzneimittelforschung; 1975 Aug; 25(8):1294-1300. PubMed ID: 241364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electroencephalographic study of Sch 161 (quazepam), a new benzodiazepine hypnotic, in rats and rabbits].
    Kawasaki H; Urabe M; Nuki C; Yamamoto R; Takasaki K; Ohno H
    Nihon Yakurigaku Zasshi; 1987 Oct; 90(4):221-38. PubMed ID: 3428780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical safety evaluation of the benzodiazepine quazepam.
    Black HE; Szot RJ; Arthaud LE; Massa T; Mylecraine L; Klein M; Lake R; Fabry A; Kaminska GZ; Sinha DP
    Arzneimittelforschung; 1987 Aug; 37(8):906-13. PubMed ID: 2890357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse.
    Hilbert J; Pramanik B; Symchowicz S; Zampaglione N
    Drug Metab Dispos; 1984; 12(4):452-9. PubMed ID: 6148212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological profile of a potential hypnotic compound RU 31158.
    Johns TG; Piper DC; James GW
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):53-65. PubMed ID: 41495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quazepam: hypnotic efficacy and side effects.
    Kales A
    Pharmacotherapy; 1990; 10(1):1-10; discussion 10-2. PubMed ID: 1969151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quazepam and flurazepam: differential pharmacokinetic and pharmacodynamic characteristics.
    Hilbert JM; Battista D
    J Clin Psychiatry; 1991 Sep; 52 Suppl():21-6. PubMed ID: 1680120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute effect of quazepam on the sleep of chronic insomniacs. A dose-response study.
    Tietz EI; Roth T; Zorick FJ; Piccione P; Kramer M
    Arzneimittelforschung; 1981; 31(11):1963-6. PubMed ID: 6119098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthesis and pharmacology of a novel benzodiazepine derivative, 1-methyl-5-(o-fluorophenyl)-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one(ID-540).
    Asami Y; Otsuka M; Hirohashi T; Inaba S; Yamamoto H
    Arzneimittelforschung; 1974 Oct; 24(10):1563-8. PubMed ID: 4154759
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationships of brain and plasma levels of quazepam, flurazepam, and their metabolites with pharmacological activity in mice.
    Hilbert JM; Iorio L; Moritzen V; Barnett A; Symchowicz S; Zampaglione N
    Life Sci; 1986 Jul; 39(2):161-8. PubMed ID: 3724367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaboxadol -- a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing.
    Ebert B; Anderson NJ; Cremers TI; Rasmussen S; Vogel V; Fahey JM; Sánchez C
    Pharmacol Biochem Behav; 2008 Jul; 90(1):113-22. PubMed ID: 18304623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the novel benzodiazepine agonist quazepam on suppressed behavior of monkeys.
    Wettstein JG
    Eur J Pharmacol; 1988 Oct; 155(1-2):19-25. PubMed ID: 2907488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
    Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
    J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quazepam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia.
    Ankier SI; Goa KL
    Drugs; 1988 Jan; 35(1):42-62. PubMed ID: 2894293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of midazolam.
    Pieri L; Schaffner R; Scherschlicht R; Polc P; Sepinwall J; Davidson A; Möhler H; Cumin R; Da Prada M; Burkard WP; Keller HH; Müller RK; Gerold M; Pieri M; Cook L; Haefely W
    Arzneimittelforschung; 1981; 31(12a):2180-201. PubMed ID: 6120698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies on CS-430, a new psychotropic agent.
    Kamioka T; Nakayama I; Hara T; Takagi H
    Arzneimittelforschung; 1978; 28(5):838-47. PubMed ID: 35173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of benzodiazepines on EEG activity and hypnogenic mechanisms of the brain stem in cats.
    Mariotti M; Ongini E
    Arch Int Pharmacodyn Ther; 1983 Aug; 264(2):203-19. PubMed ID: 6139096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonist-induced reversal of functional and structural measures of hippocampal benzodiazepine tolerance.
    Tietz EI; Zeng XJ; Chen S; Lilly SM; Rosenberg HC; Kometiani P
    J Pharmacol Exp Ther; 1999 Dec; 291(3):932-42. PubMed ID: 10565808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.